Zhejiang Medicine Co Ltd (600216) — Cash Flow-to-Debt Ratio
Zhejiang Medicine Co Ltd (600216) has a Cash Flow-to-Debt Ratio of 0.24x as of September 2025, meaning its operating cash flow of CN¥690.77 Million could theoretically repay 0% of its total liabilities (CN¥2.92 Billion) in one year. See financial agility of Zhejiang Medicine Co Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Medicine Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Zhejiang Medicine Co Ltd across 28 annual periods. For the full cash flow conversion analysis, see 600216 cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Zhejiang Medicine Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Zhejiang Medicine Co Ltd. Check Zhejiang Medicine Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.63x | CN¥1.89 Billion | CN¥3.00 Billion | ▲ +50.3% |
| 2024 | 0.42x | CN¥1.22 Billion | CN¥2.93 Billion | ▲ +84.0% |
| 2023 | 0.23x | CN¥634.31 Million | CN¥2.79 Billion | ▲ +18.8% |
| 2022 | 0.19x | CN¥520.60 Million | CN¥2.72 Billion | ▼ -43.6% |
| 2021 | 0.34x | CN¥1.14 Billion | CN¥3.35 Billion | ▼ -33.3% |
| 2020 | 0.51x | CN¥1.26 Billion | CN¥2.47 Billion | ▲ +140.0% |
| 2019 | 0.21x | CN¥447.25 Million | CN¥2.11 Billion | ▼ -28.2% |
| 2018 | 0.30x | CN¥579.91 Million | CN¥1.96 Billion | ▲ +18.1% |
| 2017 | 0.25x | CN¥503.47 Million | CN¥2.01 Billion | ▲ +35.5% |
| 2016 | 0.18x | CN¥336.14 Million | CN¥1.82 Billion | ▲ +182.8% |
| 2015 | 0.07x | CN¥106.54 Million | CN¥1.63 Billion | ▼ -84.5% |
| 2014 | 0.42x | CN¥549.90 Million | CN¥1.31 Billion | ▼ -30.9% |
| 2013 | 0.61x | CN¥655.09 Million | CN¥1.08 Billion | ▼ -35.1% |
| 2012 | 0.94x | CN¥807.49 Million | CN¥860.73 Million | ▼ -17.9% |
| 2011 | 1.14x | CN¥912.75 Million | CN¥798.63 Million | ▼ -32.8% |
| 2010 | 1.70x | CN¥1.32 Billion | CN¥773.86 Million | ▲ +18.2% |
| 2009 | 1.44x | CN¥1.47 Billion | CN¥1.02 Billion | ▲ +74.1% |
| 2008 | 0.83x | CN¥1.20 Billion | CN¥1.45 Billion | ▲ +615.4% |
| 2007 | 0.12x | CN¥227.67 Million | CN¥1.97 Billion | ▲ +19.3% |
| 2006 | 0.10x | CN¥169.51 Million | CN¥1.75 Billion | ▲ +468.1% |
| 2005 | 0.02x | CN¥25.14 Million | CN¥1.48 Billion | ▼ -81.1% |
| 2004 | 0.09x | CN¥107.60 Million | CN¥1.19 Billion | ▲ +41.7% |
| 2003 | 0.06x | CN¥66.20 Million | CN¥1.04 Billion | ▲ +177.1% |
| 2002 | 0.02x | CN¥23.13 Million | CN¥1.01 Billion | ▼ -77.6% |
| 2001 | 0.10x | CN¥98.25 Million | CN¥956.66 Million | ▲ +677.9% |
| 2000 | 0.01x | CN¥10.58 Million | CN¥801.61 Million | ▲ +127.9% |
| 1999 | -0.05x | CN¥-51.90 Million | CN¥1.10 Billion | ▼ -164.3% |
| 1998 | 0.07x | CN¥57.72 Million | CN¥782.87 Million | — |